Member Info for L2analyst

12.73p are buys now

12.64p are buys

Yes you can buy at 12.47p

Numis Securities estimates that the market for identifying and treating the Covid-19 virus could be worth $20bn (£15.4bn) a year and that the capability to manage the threat from respiratory viruses will be retained after Covid-19.

That is a great article

Prof Smythe said: “One of the ways that this test is different to other tests is that it will detect intact Covid-19 virus?,? whereas current techniques involve extracting out parts of the virus and amplifying them to detect their presence.

"Being able to detect intact virus is really important from the point of view of infectivity. With existing tests?? we know that people who have had Covid-19?,? but may no longer be infectious?,? continue to give positive results.

“Our test will be very sensitive by comparison, being able to test people accurately both before people are symptomatic and afterwards.”

Agree casper, also Bravehearta rapid mass testing is the most accurate and best in the world imo, ot could be deployed airports schools government spaces, hospitals etc

Massive usa stimulus package comming regardless of who wins it, looks like democratic

Over 58% of rms shares will be held by brh and gc, not much freefloat, Braveheart is absolutely a bargain

This is a gift horse ur looking at, we have high grade gold everywhere, just the size of resources to be confirmed, I'm Tring to add whenever possible

12.39p to buy

Its about to crack now

Just getting quote to buy 40k shares at 12.15p

NHS pay silly money long as they get their mask

Share prices getting silly even with these recent contract wins

Should blast over a 100p at least even that is cheap for this technology

What makes brh unique is that not a single dollar of value has been added to the company with all their products, current mcap is just under the value of their stake in rms! Not to mention one of the director holds over 20 per cent of the shares

Whats shocking is our mcap just under the value of 37.2 per cent stake in rms and not a single dollar has been added to rest of the products, 100 million market cap would give us almost 5 x current share price which is peanuts compare to ncyt

Casper totally agree, theres significant upside on both of these shares rms and brh, I think brh has even more upside then rms

We are valued less then our stake in rms as it continues to rise and no valuation for this and other products

"Braveheart is now pleased to confirm that Proof of Concept has now been achieved for the Capture & Signal Generation Modules, which successfully completes the Proof of Concept trials. The directors of Braveheart believe that this test will be the first to combine a rapid result with very high detection sensitivity. Work will now turn toward the acquisition of clinically relevant data, to facilitate optimisation of the functional capabilities of the test, together with a programme of product refinement and development. Meanwhile, regulatory approval for live virus trials and the acquisition of clinical data is being sought.

Trevor Brown, CEO Braveheart Investment Group, commented "This is a phenomenal achievement for all concerned. The inspirational leadership and innovative brilliance of Professor Carl Smythe and his talented team have resulted in proof of concept in a little over four months"

Unbelievable, rms going through the roof and our 37.2 per cent is more then the current mcap of this company!!